Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Oric Pharmaceuticals, Inc. (ORIC) had Operating Cash Flow per Share of $-0.59 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-41.49M |
|
-- |
|
-- |
|
$45.30M |
|
$-45.30M |
|
$3.80M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-45.30M |
|
$-44.74M |
|
108.01M |
|
108.01M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$273.69M |
|
$2.24M |
|
$130.99M |
|
$404.69M |
|
$20.76M |
|
-- |
|
$2.67M |
|
$23.43M |
|
$381.26M |
|
$381.26M |
|
$381.26M |
|
103.64M |
|
| Cash Flow Statement Financials | |
$-64.04M |
|
$-6.11M |
|
$61.97M |
|
$46.16M |
|
$37.97M |
|
$-8.19M |
|
$13.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.88% |
|
-10.88% |
|
-10.25% |
|
-10.88% |
|
$3.68 |
|
$-0.60 |
|
|
Operating Cash Flow per Share |
$-0.59 |